Global Information
회사소개 | 문의 | 비교리스트

게노믹스 시장 : 세계 업계 동향, 점유율, 규모, 성장, 기회, 예측(2020-2025년)

Genomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

리서치사 IMARC Services Private Limited
발행일 2020년 07월 상품 코드 952954
페이지 정보 영문 125 Pages
가격
US $ 2,299 ₩ 2,569,000 PDF (Single User License)
US $ 3,399 ₩ 3,799,000 PDF (5 User License)
US $ 4,499 ₩ 5,028,000 PDF (Corporate License)


게노믹스 시장 : 세계 업계 동향, 점유율, 규모, 성장, 기회, 예측(2020-2025년) Genomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025
발행일 : 2020년 07월 페이지 정보 : 영문 125 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 게노믹스 시장 구조와 동향에 대해 분석했으며, 시장의 전체적 구조, 시장 규모 추정과 예측, 컴포넌트별·용도별·기술별·최종사용자별·지역별 상세 동향, 시장 매력·경쟁 상황, 주요 기업 개요 등에 대해 조사했습니다.

제1장 서문

제2장 분석 범위와 방법

제3장 주요 요약

제4장 서론

제5장 세계의 게노믹스 시장

  • 시장 개요
  • 시장 규모 실적치
  • Covid-19의 영향

제6장 컴포넌트별 시장 내역

  • 제품
    • 주요 종류
  • 서비스
    • 주요 종류

제7장 용도별 시장 내역

  • 기능 게노믹스
  • 에피게노믹스
  • 바이오마커 발견
  • 경로 분석
  • 기타

제8장 기술별 시장 내역

  • 시퀀싱
  • 마이크로어레이
  • 중합효소 연쇄 반응
  • 핵산 추출 및 정제
  • 기타

제9장 최종사용자별 시장 내역

  • 조사 센터
  • 병원·진료소
  • 제약·바이오테크놀러지 기업
  • 기타

제10장 지역별 시장 내역

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
    • 호주
    • 인도네시아
    • 기타
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 스페인
    • 러시아
    • 기타
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 기타
  • 중동 및 아프리카
    • 국가별 시장 내역

제11장 SWOT 분석

제12장 밸류체인 분석

제13장 Porters Five Forces 분석

제14장 가격 지표

제15장 경쟁 상황

  • 시장 구조
  • 주요 기업
  • 주요 기업 개요
    • 23andMe, Inc.
    • Agilent Technologies, Inc.
    • Bayer Aktiengesellschaft
    • BGI Genomics Co. Ltd.
    • Bio-RAD Laboratories Inc.
    • Danaher Corporation
    • Illumina Inc.
    • Oxford Nanopore Technologies
    • PerkinElmer Inc.
    • Myriad Genetics Inc.
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
KSM 20.08.26

List of Figures

  • Figure 1: Global: Genomics Market: Major Drivers and Challenges
  • Figure 2: Global: Genomics Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Genomics Market: Breakup by Component (in %), 2019
  • Figure 4: Global: Genomics Market: Breakup by Application (in %), 2019
  • Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2019
  • Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2019
  • Figure 7: Global: Genomics Market: Breakup by Region (in %), 2019
  • Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 9: Global: Genomics (Products) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 11: Global: Genomics (Services) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 41: North America: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 42: North America: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 43: United States: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 44: United States: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 45: Canada: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 49: China: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 50: China: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 51: Japan: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 53: India: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 54: India: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 55: South Korea: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 57: Australia: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 59: Indonesia: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 61: Others: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 62: Others: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 63: Europe: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 65: Germany: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 67: France: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 68: France: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 69: United Kingdom: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 71: Italy: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 73: Spain: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 75: Russia: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 77: Others: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 78: Others: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 79: Latin America: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 81: Brazil: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 83: Mexico: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 85: Others: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 86: Others: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 89: Global: Genomics Industry: SWOT Analysis
  • Figure 90: Global: Genomics Industry: Value Chain Analysis
  • Figure 91: Global: Genomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Genomics Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million US$), 2020-2025
  • Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million US$), 2020-2025
  • Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million US$), 2020-2025
  • Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 7: Global: Genomics Market Structure
  • Table 8: Global: Genomics Market: Key Players

The global genomics market grew at a CAGR of around 12% during 2014-2019. Genomics refers to the study of the structure, function and inheritance of the genetic material present in the deoxyribonucleic acid (DNA) of an organism. It addresses the intrarelationship of all genes to identify their combined influence on the overall growth and development. It involves various consumables, systems, software and services for diagnostics, drug discovery, development of precision medicine and agricultural research. Some of the technologies used for genomics include microarray, sequencing, polymerase chain reaction (PCR), nucleic acid extraction and purification and single-cell genomics analysis. These techniques are highly effective in solving complex genetic problems.

The increasing adoption of non-invasive cancer screening-based research, along with the growing demand for personalized medicines, is one of the key factors driving the growth of the market. Furthermore, the rising incidences of chronic diseases is also providing a boost to the market growth. Clinical workflows are widely being integrated with genomic data for the production of targeted and personalized medicines and for studying the growth of newborn genetic screening programs and military genomics. This, along with the growing demand for genetically modified plants and organisms in the agriculture sector, is creating a positive impact on the market growth. Various technological advancements, including the development of genomics-based apps and tests, are acting as another major growth-inducing factor. Other factors, such as extensive research and development (R&D) activities in the field of bioinformatics and the increasing demand for next-generation sequencing services, are projected to drive the market further. Looking forward, IMARC Group expects the market the global genomics market to continue its strong growth during the next five years.

Breakup by Component:

  • Products
  • Instruments and Software
  • Consumables and Reagents
  • Services
  • Core Genomics Services
  • NGS-Based Services
  • Biomarker Translation Services
  • Computational Services
  • Others

Breakup by Application:

  • Functional Genomics
  • Epigenomics
  • Biomarkers Discovery
  • Pathway Analysis
  • Others

Breakup by Technology:

  • Sequencing
  • Microarray
  • Polymerase Chain Reaction
  • Nucleic Acid Extraction and Purification
  • Others

Breakup by End-User:

  • Research Centers
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being 23andMe Inc., Agilent Technologies Inc., Bayer Aktiengesellschaft, BGI Genomics Co. Ltd., Bio-RAD Laboratories Inc., Danaher Corporation, Illumina Inc., Oxford Nanopore Technologies, PerkinElmer Inc., Myriad Genetics Inc., Roche Holding AG, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report:

  • How has the global genomics market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global genomics market?
  • What is the breakup of the market based on the component?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global genomics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Genomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Products
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Instruments and Software
      • 6.1.2.2 Consumables and Reagents
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Core Genomics Services
      • 6.2.2.2 NGS-Based Services
      • 6.2.2.3 Biomarker Translation Services
      • 6.2.2.4 Computational Services
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Functional Genomics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Epigenomics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biomarkers Discovery
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pathway Analysis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Microarray
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Polymerase Chain Reaction
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nucleic Acid Extraction and Purification
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Research Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 23andMe, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Agilent Technologies, Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 BGI Genomics Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Bio-RAD Laboratories Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Danaher Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Illumina Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Oxford Nanopore Technologies
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 PerkinElmer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Myriad Genetics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Roche Holding AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis
Back to Top
전화 문의
F A Q